![]() |
The John Curtin School of Medical Research
ANU College of Medicine, Biology & Environment
|
Brain Development Laboratory
Research Interests
Research project on brain abnormalities in Hirschsprung’s disease(with Dr. David Croaker, Canberra Hospital, Canberra; Dr. Daniel Cass, Westmead Hospital, Sydney).Hirschsprung’s disease (HSCR) is a congenital malformation characterized by the absence of enteric ganglia (aganglionosis) and is associated with a variety of neurological disorders. HSCR in human, rat and mouse is polygenic, and the endothelin receptor B (ETRB) gene mutation is involved. ETRB has important roles in brains including the increase in neuronal and astrocytic proliferation and anti-apoptosis. In addition, ETRB mediates increases in cytoskeletal proteins in astrocytes associated with injury, and it increases the production of neurotrophic factors. One of our main scientific goals is to understand the cellular, molecular and functional abnormalities in the brains of HSCR patients, using a rat model of HSCR caused by an ETRB mutation (spotting lethal rat, sl rat). Our initial studies showed that substantially fewer proliferating cells but more apoptotic cells in many brain regions in spotting lethal rat, compared with normal littermates. We also expect to reveal significant changes in the biochemistry of sl rat brains, including altered levels of cytoskeletal proteins and production of neurotrophic factors and endothelins. We are conducting a battery of molecular biological and morphological tests in fetal and postnatal sl rats. Because the endothelin system interacts with the GDNF signalling system commonly involved in HSCR, our findings in the sl rat will contribute to the understanding of HSCR etiology in human. New understanding of the cellular and molecular changes in the brains of HSCR patients will allow investigation of functional defects outside the gut (e.g. autonomic and cognitive defects), and will contribute to the development of therapies for these neurological defects. s
Catecholamines (adrenaline and noradrenaline) have been implicated in regulating
neuronal maturation through various adrenoceptors. Our study (Song et al. 2004,
Neuroscience 123:405-418) demonstrates that application of alpha2 adrenoceptor
agonists significantly increases dendritic growth in primary neuronal cultures.
We further discovered that alpha2A adrenoceptors regulate dendrite growth through
alteration of the phosphorylation of microtubule-associated protein in cortical
neurons. We expanded this study to determine the effects of alpha2-ARs on the
development of dendritic spines, the small protrusions extending from the dendritic
shafts of neurons. Our results showed that application of alpha2-AR agonists,
UK 14304 or guanfacine, to cultured neurons caused significant increase in the
length and density of dendritic spines. In this project we will examine the underlying
molecular mechanisms, which may involve (1) cAMP / cAMP response element binding
protein (CREB) pathway (2) direct interaction between adrenoceptors and spinophilin,
a key protein in the spines. We will use cell culture, immunocytochemistry and
morphometric analysis, together with Western blot quantification of the levels
and phosphorylation states of CREB and spinophilin. The results will elucidate
the molecular mechanisms of adrenoceptor mediated spine development. |
|
Page last updated :: 23 August 2006 Please direct all enquiries to: Web Manager Page authorised by: Director, JCSMR |
| The Australian National University — CRICOS Provider Number 00120C |